AAO 2023: Visual field defects linked to risk of vehicular accidents in aging population


Researchers at the University of Western Australia examined declining vision and increased risk of car accidents

A man drives in cloudy conditions. Image credit: ©Marco – stock.adobe.com

A new study focuses on the specific visual field conditions and defects that can result in an increased risk of vehicular accidents. Image credit: ©Marco – stock.adobe.com

For many people, aging can affect the visual field, raising the question, is it still safe to drive? Researchers at the University of Western Australia investigated this question by examining at what point declining vision increases the risk of a car accident.

In this study, which was presented at AAO 2023, the 127th annual meeting of the American Academy of Ophthalmology, the team shared that they found that specific types of defects in an older person’s field of vision are associated with an increased risk of car crashes.

While driving laws vary across the United States, generally, states require drivers to have 20/40 vision or better in at least 1 eye to drive unrestricted. But some studies suggest that other measures of vision, such as visual field, are as important as how well a person sees on the “Big E Chart.”1

This is because the eye chart tests for our ability to see distant objects clearly while the visual field is how wide we can see when staring straight ahead. This key difference explains why a wide field of vision allows drivers to see enough details on either side of a car while still focusing on the road ahead of them.1

This is the first population-based investigation to compare a largescale ophthalmic database of visual fields for older adults with police-reported crash, licensing and hospital morbidity data. Researchers evaluated 29 years of data from more than 31,000 drivers in Western Australia aged 50 and older. Over 4,000 older drivers, accounting for 14 percent of older drivers in Western Australia, were involved in at least one car crash. More than half of those in a crash were experiencing some extent of visual field loss.1

Results suggest that the area of vision affected, and severity of it contributed significantly to crash risk:

  • Visual field loss of any sort in both eyes increased the odds of a car crash by 84 percent.
  • Moderate visual field loss in one eye increased car crash risk only if it occurred in the left upper or lower quadrants.
  • Severe vision loss in any quandrant increased the chances of an accident.
  • Central vision loss in either eye was not associated with an increase in car crash incident.

The study’s lead researcher, Siobhan Manners, MD shared how this information can better inform future laws and decisions, saying, “Many people think that only good visual acuity or clarity of vision is necessary for safe driving. We hope these results will help educate the public about the importance of having an adequate field of vision to be able to continue driving safely. We also hope to better inform clinicians, licensing authorities, and people with visual field defects of the thresholds for visual field loss that still allows for safe driving.” 1

  1. How Much Vision Loss is Too Much When it Comes to Driving?. American Academy of Ophthalmology. November 6, 2023. Accessed November 6, 2023.
Recent Videos
Theodore Leng, MD, MS, speaks about 12-Month Real-World Clinical and Anatomical Outcomes With Faricimab in Patients With Diabetic Macular Edema:The FARETINA-DME Study
Rishi P. Singh, MD, discussed his presentation on the results from part 1 of the Phase 2/3 SIGLEC trial assessing AVD-104 for GA
Carl C. Awh, MD, FASRS, speaks with Hattie Hayes of Ophthalmology Times Europe
Carl J. Danzig, MD
Martin Zinkernagel, MD, PhD, speaks about the ASRS sustainability expert panel
Srinivas Sai Kondapalli, MD, discusses outer retinal tubulations in lesion growth for subfoveal and non-subfoveal GA
Jennifer I. Lim, MD, FARVO, FASRS
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
© 2024 MJH Life Sciences

All rights reserved.